Trials / Unknown
UnknownNCT03932396
A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Instituto de Investigación Marqués de Valdecilla · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice.
Conditions
- Hepatotropic Virus Infection
- Addictive Behaviours o Conducts
- Mental Disease
- People Sentenced to Non-custodial Sentences
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational study | No intervention is planned outside of usual clinical practice. Only active screening for hepatotropic virus infection, mainly hepatitis C virus, HIV, and mental illness will be carried out. If any disease is detected, patients will be referred to the corresponding specialized care following the usual clinical practice. |
Timeline
- Start date
- 2019-05-10
- Primary completion
- 2021-03-01
- Completion
- 2021-03-31
- First posted
- 2019-04-30
- Last updated
- 2019-04-30
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03932396. Inclusion in this directory is not an endorsement.